Multi-omics uncovers interaction in the vaginal microbiome and a type II secretion/Tad pilus system in Gardnerella vaginalis
The vaginal microbiome is a critical determinant of womens health. We investigated the genetic basis of common vaginal microbiome species and their biofilm formation. Genomic analysis of Gardnerella vaginalis (Gv) revealed a fundamental phylogenetic split correlating with high- versus low-biofilm phenotypes, driven by clade-specific genomic islands and allelic variants. In a dual-species coculture model of five key vaginal bacteria, Gv achieved numerical dominance, triggering extensive, asymmetric proteomic reprogramming in partner species while showing limited shifts itself. Proteins from biofilm-associated modules showed functional divergence, supported by AI-predicted structural variations in a type II secretion/Tad pilus system, which is first discovered from Gv strains. Integrated metabolomics identified a methyl-{beta}-carboline compound that is elevated in cocultures containing Prevotella bivia (Pb). This compound acts as a potent and selective inhibitor of Gv and Pb biofilms, sparing Lactobacillus crispatus. This work establishes a direct genomic basis for Gv virulence and demonstrates how interspecies interactions govern community dynamics and antimicrobial metabolite production. HighlightsO_LIComprehensive genomic resource comparing with high-quality long-read whole genomes and reference Gardnerella vaginalis and Lactobacillus iners strains. C_LIO_LIIntegrated multi-omics and functional analysis on the most common vaginal microbiome species using 16S rRNA gene sequencing, proteomics, metabolomics, and in vitro assays. C_LIO_LIKey phenotypes quantified, including biofilm formation and polymicrobial interactions. C_LIO_LIConserved Type II Secretion/Tad Pilus System identified across all Gardnerella vaginalis strains, with AI-predicted structural modeling. C_LIO_LIEvaluation of growth inhibition using metabolites against a panel of relevant microbes, including vaginal microbes and opportunistic pathogens. C_LI